Evotec to attend upcoming investor conferences

 

Hamburg, Germany, 06 September 2019:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that its management will be presenting at and attending the following upcoming conferences:

J.P. Morgan Cazenove Pan-European Small/Mid Cap Conference, London, UK

  • Date: Wednesday, 11 September 2019
  • Venue: London, UK
  • Attendee: Enno Spillner, Chief Financial Officer

 

Bank of America Merrill Lynch Global Healthcare Conference 2019, London, UK

  • Date: Wednesday, 18 September 2019,
             Presentation: 18 September 2019, 4.25 pm BST
  • Venue: London, UK
  • Attendee: Werner Lanthaler, Chief Executive Officer

 

Baader Investment Conference, Munich, Germany

  • Date: Monday, 23 September 2019,
             Presentation: 23 September 2019, 5.15 pm CEST
  • Venue: Munich, Germany
  • Attendee: Enno Spillner, Chief Financial Officer

 

Berenberg and Goldman Sachs Eighth German Corporate Conference, Munich, Germany

  • Date: Tuesday, 24 September 2019,
              Presentation: 24 September 2019, 2.30 pm CEST
  • Venue: Munich, Germany
  • Attendee: Enno Spillner, Chief Financial Officer

 

Ladenburg Thalmann Healthcare Conference, New York, NY, USA

  • Date: Tuesday, 24 September 2019,
             Presentation: 24 September 2019, 10.30 am EDT
  • Venue: New York, NY, USA
  • Attendee: Dr Werner Lanthaler, Chief Executive Officer

 

2019 Cantor Global Healthcare Conference, New York, NY, USA

  • Date: Wednesday, 02 October 2019,
             Presentation: 02 October 2019, 3.00 pm EDT
  • Venue: New York, NY, USA
  • Attendee: Dr Werner Lanthaler, Chief Executive Officer
FORWARD-LOOKING STATEMENTS

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.